Consolidated Statements of Cash Flows - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021
Operating activities:
Net income (loss)		$ 23,385		$ (56,235)		$ 4,655,997
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Equity-based compensation		654,922		627,714		0
Performance allocation compensation		591,676		416,556		0
Net (gains) losses from investment activities		(6,564)		110,131		(353,219)
Capital allocation-based income		(855,285)		(756,252)		(3,998,483)
Other non-cash activities		100,628		29,939		45,729
Unrealized gains from investment activities of consolidated TPG Funds and Public SPACs		(667)		(12,382)		(235,214)
Changes in operating assets and liabilities:
Due from affiliates		41,268		(42,378)		(42,826)
Accounts payable and accrued expenses		(231,542)		(14,235)		51,148
Due to affiliates		(161,833)		(12,528)		11,129
Accrued performance allocation compensation		(505,024)		(672,375)		0
Net cash provided by operating activities		720,518		1,375,878		1,474,820
Investing activities:
Acquisitions, net of cash acquired (Note 3)		(356,835)		0		24,817
Repayments of notes receivable from affiliates		0		14,937		23,282
Advances on notes receivable from affiliates		0		(15,500)		(9,053)
Purchases of fixed assets		(16,728)		(2,449)		(1,791)
Transfers related to Reorganization Activities		0		0		(75,000)
Net cash used in investing activities		(373,563)		(3,012)		(37,745)
Financing activities:
Proceeds from issuance of common stock in IPO, net of underwriting and issuance costs		0		770,865		0
Proceeds from issuance of common stock from underwriters' exercise of over-allotment option, net of underwriting and issuance costs		0		49,756		0
Purchase of partnership interests with IPO proceeds		0		(379,597)		0
Reorganization activities		0		2,124		0
Proceeds from debt obligations		651,000		30,000		200,000
Repayment of debt obligations		(150,000)		(30,000)		(50,000)
Issuance costs on debt obligations		(900)		0		(520)
Withholding taxes paid on net settlement of equity-based awards		(6,878)		0		0
Dividends/Distributions		(643,224)		(662,812)		0
Distributions to partners prior to Reorganization and IPO		0		(355,282)		(1,066,680)
Redemption of redeemable equity		(661,001)		(352,014)		(304,760)
Net cash used in financing activities		(789,234)		(1,238,080)		(1,322,566)
Net change in cash, cash equivalents and restricted cash		(442,279)		134,786		114,509
Cash, cash equivalents and restricted cash, beginning of period		1,120,650		985,864		871,355
Cash, cash equivalents and restricted cash, end of period		678,371		1,120,650		985,864
Supplemental disclosures of other cash flow information:
Cash paid for income taxes		51,130		48,327		8,548
Cash paid for interest		33,549		18,352		15,728
Supplemental disclosures of non-cash operating activities:
Investment in equity method investments		0		0		(3,138)
In-kind proceeds from investments		0		0		36,334
Increase in due from affiliates		0		0		(3,045)
Supplemental disclosures of non-cash investing and financing activities:
Reorganization		0		0		(952,411)
NewQuest contingent consideration		0		0		8,400
Common Units		0		0		24,600
Distributions in-kind to holders of other non-controlling interests		0		0		(33,197)
Distributions payable to partners		0		0		352,722
Distributions payable to holders of other non-controlling interests		17,779		3,964		355,282
Repayments of notes receivable to affiliates		0		0		3,045
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents		665,188		1,107,484		972,729
Restricted cash		13,183	[1]	13,166	[1]	13,135
Cash, cash equivalents and restricted cash, end of period		678,371		1,120,650		985,864
Consolidated Entity, Excluding VIE
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Net (gains) losses from investment activities		(6,564)		110,131		(353,219)
Changes in operating assets and liabilities:
Purchases of investments		(303,118)		(109,093)		(173,885)
Investments		798,478		1,567,684		2,179,064
Other assets		(44,475)		(35,893)		(22,586)
Other liabilities		(40,283)		(22,515)		(26,931)
Financing activities:
Purchase of partnership interests with IPO proceeds		0		(318,942)		(1,009,242)
Contributions from holders of other non-controlling interests		21,769		7,822		4,636
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents		665,188		1,107,484
Variable Interest Entity, Not Primary Beneficiary
Changes in operating assets and liabilities:
Purchases of investments		0		0		(216,657)
Investments		0		0		218,695
Other assets		457		18,611		(12,583)
Other liabilities		(237)		(7,537)		19,884
Cash and cash equivalents		5,097		274		5,839
Assets held in Trust Accounts		653,635		346,392		(630,281)
Financing activities:
Proceeds from issuance of common stock in IPO, net of underwriting and issuance costs		0		0		935,000
Purchase of partnership interests with IPO proceeds		0		0		(12,840)
Payments of underwriting and offering costs		0		0		(18,700)
Proceeds from Noncontrolling Interests		0		0		540
Supplemental disclosures of non-cash investing and financing activities:
Deferred underwriting related to Public SPACs		22,750		12,250		$ (35,441)
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents	[1]	$ 0		$ 5,097

[1] The Company’s consolidated total assets and liabilities as of December 31, 2023 and December 31, 2022 include assets and liabilities of variable interest entities (“VIEs”). The assets can be used only to satisfy obligations of the VIEs, and the creditors of the VIEs have recourse only to these assets, and not to TPG Inc. These amounts include the assets and liabilities of consolidated Public SPACs, restricted cash, assets pledged of securitization vehicles, secured borrowings of securitization vehicles, and redeemable equity of consolidated Public SPACs. See Notes 2, 11, 12 and 15 to the Consolidated Financial Statements